Loading, please wait ...


News Analytics

.
The MTD of OX-IRIS therapy was estimated to be level 0 (oxaliplatin, 85 mg/m 2 ; irinotecan, 100 mg/m 2 ; S-1, 80 mg/m 2 ), and the RD was determined to be level −1 (oxaliplatin, 65 mg/m 2 ; irinotecan, 100 mg/m 2 ; S-1, 80 mg/m 2 ) in the present phase I trial. We are now evaluating the efficacy and safety in a phase II study of the OX-IRIS therapy.

The Angle

Subject Matter

  • Healthcare 100.00%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions

Dimensions/Depth Chart

If you find a dimension intereseting, we recommend you pick up one or two facts that you find intriguing and place them into your memory. That way you will have 2nd degree information about the topic if it comes up in conversation.

Accordingly, you can do the same with others as well.